WeVote
Log In

Bill

Bill

SF 4957

Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provision

2025-2026 Regular Session Introduced by Susan Pha

The bill expands access by increasing the number of patients an RDC can serve and the allowable cannabis plants for patients, with updated caregiver rules.

Referred to Commerce and Consumer Protection
#commerceandcommercedepartment #drugsandmedicine #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 4957

Summary of SF 4957 (Minnesota) – 2025-2026 Session

Overview

SF 4957 is a Minnesota Senate bill titled “Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provision.” The bill seeks to modify rules related to registered designated caregivers (RDCs) in Minnesota’s medical cannabis program, with accompanying changes to patient and cannabis plant limits. The sponsor listed is a co-sponsor: Susan Pha. The bill was introduced and referred to the Commerce and Consumer Protection committee on April 7, 2026.

Purpose and Intent

  • To modify the regulatory framework governing registered designated caregivers within Minnesota’s medical cannabis program.
  • To expand access by increasing limits on the number of patients a registered designated caregiver can assist.
  • To increase the permissible cannabis plant counts for patients, potentially enabling broader patient cultivation or production capacity under the program.

Key Provisions (as described by the title)

Note: The specific textual provisions are not provided in the summary you supplied, but the title indicates the following areas are the focus:

  1. Modifications to Registered Designated Caregivers (RDCs) Provisions

    • Revisions to eligibility, duties, or governance of RDCs.
    • Adjustments to registration processes, oversight, or compliance requirements for RDCs.
    • Possible changes to eligibility criteria for caregivers (e.g., relationship to patient, residency, or training requirements).

  2. Increasing Patient Limits

    • Expansion of the number of patients a single RDC may serve.
    • Possible accompanying safeguards (e.g., caps, reporting, or physician oversight) to ensure patient safety and program integrity.

  3. Cannabis Plant Limits Expansion

    • Increase in the allowable number of cannabis plants permitted for patients under the medical cannabis program.
    • Potential milestones or tiered limits based on patient category or state license status.
    • Clarifications regarding cultivation responsibilities, security, and record-keeping.

Who Would Be Affected

  • Registered Designated Caregivers (RDCs): Changes to eligibility, duties, oversight, and registration could broaden or tighten their role and responsibilities.
  • Patients enrolled in Minnesota’s medical cannabis program: If plant limits increase, patients could cultivate more plants or obtain greater supply, potentially impacting access and cost.
  • Medical cannabis program administration and dispensaries: Administrative processes, compliance reporting, and enforcement provisions may be updated to reflect the new limits and caregiver roles.
  • Physicians/medical providers: If physician oversight or patient eligibility criteria are adjusted, prescribers may interact with the updated caregiver framework more or differently.

Procedural and Timeline Aspects

  • Introduction and First Reading: April 7, 2026.
  • Referral: Referred to the Commerce and Consumer Protection committee on April 7, 2026.
  • The bill will move through the committee process, including potential hearings, amendments, and a floor vote, before any formal passage.
  • If advanced, the bill would typically proceed to the Senate floor for consideration and, if passed, proceed to the House (or appropriate legislative path) for reconciliation with any companion measures.

Potential Impacts and Considerations

  • Access vs. Oversight: Higher patient and plant limits could improve patient access but may necessitate enhanced monitoring to prevent diversion, ensure product safety, and maintain program integrity.
  • Caregiver Workload: Increasing the number of patients per RDC could affect the quality and consistency of caregiver support; implementation might require additional training or capacity-building measures.
  • Program Costs and Compliance: Changes may shift administrative costs, reporting requirements, and compliance burdens for RDCs and the state agency administering the program.
  • Security and Compliance: Any expansion of plant limits typically comes with stricter security, inventory controls, and traceability requirements.

If you’d like, I can tailor this summary further once the bill’s specific text is available (e.g., detail exact numerical limits, eligibility changes, or amended statutory language).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.